P

Inventor

ORWAT MICHAEL J

US35 patents
⚠️ This page may combine multiple inventors who share the name “ORWAT MICHAEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

27 patents
US8367709B2Feb 5, 2013

Dipeptide analogs as coagulation factor inhibitors

BRISTOL MYERS SQUIBB CO42 citations94
US9453018B2Sep 27, 2016

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO13 citations92
US7312214B2Dec 25, 2007

1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO58 citations90
US9192607B2Nov 24, 2015

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US9108951B2Aug 18, 2015

Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9000172B2Apr 7, 2015

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US7371761B2May 13, 2008

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO12 citations83
US9944625B2Apr 17, 2018

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations73
US11053247B2Jul 6, 2021

Pyrimidinones as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US10336754B2Jul 2, 2019

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US9777001B2Oct 3, 2017

Macrocycles with aromatic P2′ groups as factor xia inhibitors

BRISTOL MYERS SQUIBB CO3 citations72
US7371864B2May 13, 2008

Crystalline forms of a factor Xa inhibitor

BRISTOL MYERS SQUIBB CO7 citations71
US12428421B2Sep 30, 2025

Pyrimidinones as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US10676477B2Jun 9, 2020

Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group

BRISTOL MYERS SQUIBB CO2 citations62
US10000466B2Jun 19, 2018

Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US9447110B2Sep 20, 2016

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO1 citations62
US10611776B2Apr 7, 2020

Spiroheptane salicylamides and related compounds as inhibitors of rock

BRISTOL MYERS SQUIBB CO1 citations61
US11306081B2Apr 19, 2022

Phenylacetamides as inhibitors of rock

BRISTOL MYERS SQUIBB CO0 citations52
US10208021B2Feb 19, 2019

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9725435B2Aug 8, 2017

Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US9394276B2Jul 19, 2016

Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US10829501B2Nov 10, 2020

Spiroheptane salicylamides and related compounds as inhibitors of ROCK

BRISTOL MYERS SQUIBB CO0 citations50
US9738655B2Aug 22, 2017

Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO1 citations49
US9403774B2Aug 2, 2016

Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors

BRISTOL MYERS SQUIBB CO0 citations42
US9315519B2Apr 19, 2016

Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations42
US10273236B2Apr 30, 2019

Macrocyclic factor XIa inhibitors bearing heterocyclic groups

BRISTOL MYERS SQUIBB CO0 citations41
US9079929B2Jul 14, 2015

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO0 citations41

BRISTOL MYERS SQUIBB PHARMA CO

4 patents

DU PONT MERCK PHARMA

4 patents